课题基金 / 基金详情

CLINICAL CENTERS FOR FEASIBILITY STUDIES ON RETINOID TRE

CLINICAL CENTERS FOR FEASIBILITY STUDIES ON RETINOID TRE
维甲酸 TRE 可行性研究临床中心
批准号:
6356163
负责人:
Michael D Roth
金额:
$81.72万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-10-12 至 2002-09-29

项目摘要

项目成果

Michael D Roth的其他基金

相似基金

相关文献

中文摘要
翻译
维甲酸治疗肺气肿的可行性(FORTE)研究的总体目标是在5个临床中心进行初步研究,准备进行一项关于维甲酸治疗肺气肿疗效的随机对照临床试验。目标是确定最佳的患者人群,药物和给药方案,以及大型研究的结局指标(如有指征)。本项目作为本研究的临床中心。
英文摘要
The overall objective of the Feasibility of Retinoic Acid Treatment in Emphysema (FORTE) study is to conduct preliminary studies at 5 clinical centers preparatory to conducting a randomized, controlled, clinical trial on the efficacy of retinoic acid therapy in the management of emphysema. Objectives are to identify optimal patient populations, drugs and dosing schedules, and outcome measures for a large study, if indicated. This project serves as a clinical center for the study.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Marijuana smoke promotes dysfunctional macrophage responses to HIV and pneumonia
Marijuana smoke promotes dysfunctional macrophage responses to HIV and pneumonia
Marijuana smoke promotes dysfunctional macrophage responses to HIV and pneumonia
EVALUATING EFFECTS OF MARIJUANA SMOKING ABILITY TO RESPOND TO HEPATITIS B VACCIN
海外基金